Group 1 - The core point of the announcement is that Wu Kaiti, a shareholder holding more than 5% of the shares, plans to reduce his stake in the company by up to 3% of the total share capital within three months starting from 15 trading days after the announcement [1] - Wu Kaiti currently holds 7.9328 million shares, which represents 13.08% of the company's total share capital [1] - The reduction will occur through centralized bidding or block trading, with a maximum of 606,500 shares (1% of total share capital) to be sold via centralized bidding and up to 1.213 million shares (2% of total share capital) through block trading [1] Group 2 - The reduction period is set from February 2, 2026, to May 1, 2026, with the selling price determined by market conditions [1]

证券日报网讯 1月8日，键凯科技在互动平台回答投资者提问时表示，LIHONGGUO女士目前担任键凯 科技董事、副总经理，美国键凯经营副总裁，主管公司国际销售业务。 （文章来源：证券日报） ...

Core Viewpoint - JianKai Technology experienced significant trading activity on January 5, with a total of 12 block trades amounting to 550,600 shares and a total transaction value of 41.90 million yuan, reflecting a discount of 17.17% compared to the closing price of the day [2][3] Trading Activity Summary - The stock's closing price on January 5 was 91.88 yuan, marking an increase of 11.78% with a turnover rate of 3.71% and a total trading volume of 201 million yuan, while there was a net outflow of 711,900 yuan in main funds [2] - Over the past five days, the stock has risen by 11.44%, with a total net inflow of 2.36 million yuan [2] - In the last three months, there have been 31 block trades for the stock, with a cumulative transaction value of 91.63 million yuan [2] Margin Trading Data - The latest margin financing balance for the stock is 172 million yuan, which has increased by 3.52 million yuan over the past five days, representing a growth rate of 2.08% [2]

证券代码：688356 证券简称：键凯科技 公告编号：2026-001 北京键凯科技股份有限公司 持股 5%以上股东权益变动触及 1%刻度暨减持股份 结果公告 投资者吴凯庭保证向本公司提供的信息真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 一、减持主体减持前基本情况 大股东持有的基本情况 本次减持计划实施前，北京键凯科技股份有限公司（以下简称"公司"） 股东吴凯庭持有公司股份 9,145,847 股，占公司总股本的 15.08%。 上述股份来源为公司首发前股份，已于 2023 年 8 月 28 日解除限售。 减持计划的实施结果情况 2025 年 9 月 9 日，公司披露了《持股 5%以上股东减持股份计划公告》 （公告编号：2025-029）。减持计划主要内容如下： 因股东自身资金需求，吴凯庭计划自本公告披露之日起 15 个交易日后 的 3 个月内通过大宗交易方式减持公司股份不超过 1,213,014 股，拟 减持比例不超过公司总股本的 2%。 | 股东名称 | 吴凯庭 | | | | --- | --- | --- ...

Group 1 - The core point of the article is that JianKai Technology (688356.SH) has received a notice from shareholder Wu Kaiting regarding a reduction in shareholding that has crossed the 1% threshold [1] - Wu Kaiting reduced his shareholding from 9,097,647 shares to 7,932,833 shares, representing a decrease from 15.00% to 13.08% of the company's total share capital [1] - The share reduction was executed through block trading from December 22, 2025, to January 5, 2026, and the reduction plan has been completed as of the announcement date [1]

格隆汇1月5日丨键凯科技(688356.SH)公布，公司于近日收到股东吴凯庭出具的《关于权益变动触及1% 刻度暨减持股份结果的告知函》，股东吴凯庭于2025年12月22日至2026年1月5日通过大宗交易方式减持 公司股份1,164,814股，所持公司股份数量由9,097,647股减少至7,932,833股，占公司总股本的比例由 15.00%减少至13.08%，权益变动触及1%刻度。截至本公告披露日，本次减持计划已实施完毕。 ...

Core Viewpoint - JianKai Technology executed a block trade of 550,600 shares on January 5, with a transaction value of 41.9017 million yuan, representing 17.26% of the total trading volume for the day. The transaction price was 76.1 yuan, reflecting a discount of 17.17% compared to the market closing price of 91.88 yuan [1]. Group 1 - The block trade involved a total of 550,600 shares of JianKai Technology [1]. - The transaction amount was 41.9017 million yuan, which is approximately 6.4 million USD [1]. - The transaction price of 76.1 yuan was significantly lower than the market closing price, indicating a discount of 17.17% [1].

Group 1 - The chemical pharmaceutical sector increased by 3.63% on January 5, with Frontier Biotech leading the gains [1] - The Shanghai Composite Index closed at 4023.42, up 1.38%, while the Shenzhen Component Index closed at 13828.63, up 2.24% [1] - Notable stock performances included Frontier Biotech with a closing price of 21.20, up 17.45%, and Beilu Pharmaceutical at 66.8, up 13.22% [1] Group 2 - The chemical pharmaceutical sector saw a net inflow of 716 million yuan from institutional investors, while retail investors contributed a net inflow of 131 million yuan [2] - Major stocks with significant net inflows included Heng Rui Pharmaceutical with 17.4 million yuan and ST Renfu with 9.15 million yuan [3] - Conversely, stocks like ST Jinfeng and Kangzhiyue experienced net outflows of 6.90 million yuan and 11.61 million yuan respectively [2][3]

Group 1 - Key Point 1: JianKai Technology's stock closed at 82.20 yuan, with a slight increase of 0.02% on December 31 [1] - Key Point 2: A total of 6 block trades occurred, with a combined trading volume of 270,000 shares and a total transaction amount of 20.115 million yuan [1] - Key Point 3: The first four trades were executed at a price of 74.50 yuan per share, each with a premium rate of -9.37% [1] Group 2 - Key Point 1: The fifth and sixth trades also occurred at 74.50 yuan per share, maintaining the same premium rate of -9.37% [2] - Key Point 2: In the last three months, there have been 19 block trades for this stock, totaling a transaction amount of 49.729 million yuan [2] - Key Point 3: Over the last five trading days, the stock has increased by 0.81%, with a net inflow of 823,400 yuan from main funds [2]

Group 1 - Key Point 1: On December 31, JianKai Technology executed a block trade of 270,000 shares, with a transaction value of 20.115 million yuan, accounting for 50.42% of the total trading volume for that day [1] - Key Point 2: The transaction price was 74.5 yuan, which represents a discount of 9.37% compared to the market closing price of 82.2 yuan [1] Group 2 - Key Point 1: The block trade involved multiple transactions on the same date, all at the price of 74.5 yuan, with varying transaction amounts and volumes [2] - Key Point 2: The total transaction amounts for the various trades ranged from 201.15 million yuan to 625.8 million yuan, indicating significant trading activity [2]